Ertugliflozin Impuity SA36802
| CAS No. | : NA |
| Mol F. | : C28H33ClO13 |
| Mol W. | : 613 |
| Cat No. | : SA36802 |
- Description
- Quick Enquiry / RFQ
Description
| Product Name | Ertugliflozin Impuity SA36802 |
| Synonyms | (1R,2R,3S,4R,5R)-5-((1S,2S,3S,4R,5S)-5-(4-chloro-3-(4-ethoxybenzyl)phenyl)-2,3-dihydroxy-1-(hydroxymethyl)-6,8-dioxabicyclo[3.2.1]octan-4-yloxy)-2,3,4-trihydroxycyclohexanecarboxylic acid |
| Related API | Ertugliflozin |
| Category | Impurities |
Ertugliflozin Impuity SA36802 product with CAS: NA is also known as (1R,2R,3S,4R,5R)-5-((1S,2S,3S,4R,5S)-5-(4-chloro-3-(4-ethoxybenzyl)phenyl)-2,3-dihydroxy-1-(hydroxymethyl)-6,8-dioxabicyclo[3.2.1]octan-4-yloxy)-2,3,4-trihydroxycyclohexanecarboxylic acid; . This product can be used as a working standard or secondary reference standard (additional internal validation as per respective FDA regulations/guidelines may require). Ertugliflozin Impuity SA36802 is used in Ertugliflozin impurity profiling as per limits and threshold values specified by respective drug legislation, FDA, and pharmacopoeial guidelines during commercial production of Ertugliflozin and its related formulations. Moreover, (1R,2R,3S,4R,5R)-5-((1S,2S,3S,4R,5S)-5-(4-chloro-3-(4-ethoxybenzyl)phenyl)-2,3-dihydroxy-1-(hydroxymethyl)-6,8-dioxabicyclo[3.2.1]octan-4-yloxy)-2,3,4-trihydroxycyclohexanecarboxylic acid is also used in the process of Abbreviated New Drug Application (ANDA) filing to FDA and toxicity study of respective drug formulation. Please also find out other impurities of Ertugliflozin developed in our R&D.
Product quantity / packs as per your requirement, just let us know!
Please contact us or email us at [email protected]
